DMT1-mutant erythrocytes have shortened life span, accelerated glycolysis and increased oxidative stress

Cellular Physiology and Biochemistry

Volumn 34, Issue 6, 2014, Pages 2221-2231

  Zidova, Zuzana ^a   Kapralova, Katarina ^a   Koralkova, Pavla ^a   Mojzikova, Renata ^a   Dolezal, Dalibor ^a   Divoky, Vladimir ^a   Horvathova, Monika ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

DMT1; Eryptosis; Oxidative stress

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCOSE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PHOSPHATIDYLSERINE; REACTIVE OXYGEN METABOLITE; CATION TRANSPORT PROTEIN; SOLUTE CARRIER FAMILY 11- (PROTON-COUPLED DIVALENT METAL ION TRANSPORTERS), MEMBER 2;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROBLAST; ERYTHROCYTE; ERYTHROCYTE LIFESPAN; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; FLUORESCENCE ACTIVATED CELL SORTING; GLYCOLYSIS; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPEROSMOTIC STRESS; IN VITRO STUDY; IRON DEFICIENCY ANEMIA; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; ANIMAL; BLOOD; DEFICIENCY; DISEASE MODEL; ERYTHROPOIESIS; GENETICS; HUMAN; METABOLISM; MUTATION; PATHOLOGY;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANEMIA, HYPOCHROMIC; ANIMALS; APOPTOSIS; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; ERYTHROCYTES; ERYTHROPOIESIS; GLYCOLYSIS; HUMANS; MICE; MUTATION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84920883504     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000369665     Document Type: Article

References (38)

1. Gunshin H, Fujiwara Y, Custodio AO, Direnzo C, Robine S, Andrews NC: Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J Clin Invest 2005;115:1258-1266
2. Mims MP, Guan Y, Pospisilova D, Priwitzerova M, Indrak K, Ponka P, Divoky V, Prchal JT: Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 2005;105:1337-1342
3. Iolascon A, d'Apolito M, Servedio V, Cimmino F, Piga A, Camaschella C: Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 2006;107:349-354
4. Beaumont C, Delaunay J, Hetet G, Grandchamp B, de Montalembert M, Tchernia G: Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 2006;107:4168-4170
5. Blanco E, Kannengiesser C, Grandchamp B, Tasso M, Beaumont C: Not all DMT1 mutations lead to iron overload. Blood Cells Mol Dis 2009;43:199-201
6. Bardou-Jacquet E, Island ML, Jouanolle AM, Détivaud L, Fatih N, Ropert M, Brissot E, Mosser A, Maisonneuve H, Brissot P, Loréal O: A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload. Blood Cells Mol Dis 2011;47:243-248
7. Fleming MD, Trenor CC 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC: Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-386
8. Fleming MD, Romano MA, Su MA, Garrick LM, Garrick MD, Andrews NC: Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc Natl Acad Sci U S A 1998;95:1148-1153
9. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370
10. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T: Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-372
11. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F: Mechanisms of suicidal erythrocyte death. Cell Physiol Biochem 2005;15:195-202
12. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythrocytes. Cell Death Differ 2003;10:249-256
13. Duranton C, Huber SM, Lang F: Oxidation induces a Cl(-)-dependent cation conductance in human red blood cells. J Physiol 2002;539:847-855
14. Horvathova M, Kapralova K, Zidova Z, Dolezal D, Pospisilova D, Divoky V: Erythropoietin-driven signaling ameliorates the survival defect of DMT1-mutant erythroid progenitors and erythroblasts. Haematologica 2012;97:1480-1488
15. Goodman SR, Hughes KM, Kakhniashvili DG, Neelam S: The isolation of reticulocyte-free human red blood cells. Exp Biol Med (Maywood) 2007;232:1470-1476
16. Qadri SM, Mahmud H, Lang E, Gu S, Bobbala D, Zelenak C, Jilani K, Siegfried A, Föller M, Lang F: Enhanced suicidal erythrocyte death in mice carrying a loss-of-function mutation of the adenomatous polyposis coli gene. J Cell Mol Med 2012;16:1085-1093
17. Akel A, Wagner CA, Kovacikova J, Kasinathan RS, Kiedaisch V, Koka S, Alper SL, Bernhardt I, Wieder T, Huber SM, Lang F: Enhanced suicidal death of erythrocytes from gene-Targeted mice lacking the Cl-/HCO(3)(-) exchanger AE1. Am J Physiol Cell Physiol 2007;292:C1759-C1767
18. Ghashghaeinia M, Toulany M, Saki M, Bobbala D, Fehrenbacher B, Rupec R, Rodemann HP, Ghoreschi K, Röcken M, Schaller M, Lang F, Wieder T: The NF?B pathway inhibitors Bay 11-7082 and parthenolide induce programmed cell death in anucleated Erythrocytes. Cell Physiol Biochem 2011;27:45-54
19. Streichman S, Gescheidt Y: Cryohemolysis for the detection of hereditary spherocytosis: correlation studies with osmotic fragility and autohemolysis. Am J Hematol 1998;58:206-212
20. Cruickshank AM: ACP Best Practise No 166: CSF spectrophotometry in the diagnosis of subarachnoid haemorrhage. J Clin Pathol 2001;54:827-830
21. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Götz F, Döring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med (Berl) 2007;85:273-281
22. Amer J, Dana M, Fibach E: The antioxidant effect of erythropoietin on thalassemic blood cells. Anemia 2010;2010:978710
23. Beutler E, Blume KG, Kaplan JC, Löhr GW, Ramot B, Valentine WN: International Committee for Standardization in Haematology: recommended methods for red-cell enzyme analysis. Br J Haematol 1977;35:331-340
24. Mojzikova R, Dolezel P, Pavlicek J, Mlejnek P, Pospisilova D, Divoky V: Partial glutathione reductase deficiency as a cause of diverse clinical manifestations in a family with unstable hemoglobin (Hemoglobin Haná, β63(E7) His-Asn). Blood Cells Mol Dis 2010;45:219-222
25. Mojzikova R, Koralkova P, Holub D, Zidova Z, Pospisilova D, Cermak J, Striezencova Laluhova Z, Indrak K, Sukova M, Partschova M, Kucerova J, Horvathova M, Divoky V: Iron status in patients with pyruvate kinase deficiency: neonatal hyperferritinaemia associated with a novel frameshift deletion in the PKLR gene (p.Arg518fs), and low hepcidin to ferritin ratios. Br J Haematol 2014;165:556-563
26. Arnstein HR, Cox RA, Hunt JA: The function of high-molecular-weight ribonucleic acid from rabbit reticulocytes in haemoglobin biosynthesis. Biochem J 1964;92:648-661
27. Bakker WJ, Harris IS, Mak TW: FOXO3a is activated in response to hypoxic stress and inhibits HIF1-induced apoptosis via regulation of CITED2. Mol Cell 2007;28:941-953
28. Kapralova K, Lanikova L, Lorenzo F, Song J, Horvathova M, Divoky V, Prchal JT: RUNX1 and NF-E2 upregulation is not specific for MPNs, but is seen in polycythemic disorders with augmented HIF signaling. Blood 2014;123:391-394
29. Pfaffl MW, Horgan GW, Dempfle L: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-Time PCR. Nucleic Acids Res 2002;30:E36
30. Xu H, Jin J, DeFelice LJ, Andrews NC, Clapham DE: A spontaneous, recurrent mutation in Divalent metal transporter-1 exposes a calcium entry pathway. PLoS Biol 2004;2:E50
31. van Wijk R, van Solinge WW: The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 2005;106:4034-4042
32. Canonne-Hergaux F, Zhang AS, Ponka P, Gros P: Characterization of the iron transporter DMT1 (NRAMP2/ DCT1) in red blood cells of normal and anemic mk/mk mice. Blood 2001;98:3823-3830
33. Priwitzerova M, Pospisilova D, Indrak K, Ponka P, Divoky V: Consequences of DMT1 mutation on proliferation and hemoglobinization of erythroid progenitors in vitro. Blood (ASH Annual Meeting Abstracts) 2004;104: Abstract 3190
34. Lang F, Lang E, Föller M: Physiology and pathophysiology of eryptosis. Transfus Med Hemother 2012;39:308-314
35. Nagababu E, Gulyani S, Earley CJ, Cutler RG, Mattson MP, Rifkind JM: Iron-Deficiency Anemia Enhances Red Blood Cell Oxidative Stress. Free Radic Res 2008; 42:824-829
36. Rogers SC, Said A, Corcuera D, McLaughlin D, Kell P, Doctor A: Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J 2009;23:3159-3170
37. Lang F, Qadri SM: Mechanisms and significance of eryptosis, the suicidal death of erythrocytes. Blood Purif 2012;33:125-130
38. Sprague RS, Stephenson AH, Ellsworth ML: Red not dead: signaling in and from erythrocytes. Trends Endocrinol Metab 2007;18:350-355